Abstract
Recent technological breakthroughs allowing for large-scale analysis of gene transcripts and large-scale monitoring of the immune response with protein chips are revealing new participants in the pathogenesis of multiple sclerosis. Some of these participants may be useful targets for therapy.
Original language | English |
---|---|
Pages (from-to) | 491 - 505 |
Number of pages | 15 |
Journal | Annual Review of Neuroscience |
Volume | 25 |
Publication status | Published - 2002 |